Sepsis Diagnostics Products and Market Trends
The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently. In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths. Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.
This report provides comprehensive information on products in the sepsis market, as well as:
The diagnosis of sepsis is not straightforward. Blood culture analysis has remained a gold standard, despite the fact that it is typically slow and labor-intensive. The complexity of sepsis and the overlap with infectious diseases causes this field to comprise a very large range of products and technologies. This report takes into consideration the status of sepsis as a disease present within many other diseases. A special section on COVID-19 is included.
This report does cover many of the systems and products that diagnose infectious diseases, with an emphasis on rapid or multiplexed tests; but it does not provide a comprehensive breakdown of products for infectious disease detection. There is also a variety of other tests that are only touched upon, which also may be run depending on the appropriate action-blood gases, bilirubin, creatinine, platelets, etc.
Products from the following companies are considered in this report: